Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
TRAFFIX logo

A new study called TrAFFix (Trial of Acute Femoral Fracture Fixation) has just opened at  the John Radcliffe Hospital in Oxford. TrAFFix will compare two different methods of fixing breaks of the thigh bone (femur), and will be rolled out across 6 hospitals in England over the next few months.

Participants aged 50 or over, who have a break in the lower part of their thigh bone (femur), may be eligible to take part. The study will help the planning of a future large trial by measuring recruitment, the completion rate of questionnaires, and assessing participant and staff impressions of the research. The future trial will compare differences in quality of life outcome when patients receive one of two common types of fixation.

TrAFFix is funded by the NIHR Health Technology Assessment Programme (Ref: 15/59/22).

Similar stories

AVID-CC trial opens to recruitment!

OCTRU

The AVID-CC trial has received OCTRU Green Light approval and is now open to recruitment!

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.

WHiTE Four trial results!

OCTRU

The WHiTE Four trial has now published its results in The Bone & Joint journal.

FUTURE GB Trial opens to recruitment!

OCTRU

The FUTURE GB Trial has received OCTRU Green Light approval and is now open to recruitment!

ARCADIAN trial opens to recruitment!

OCTRU

The ARCADIAN trial has received OCTRU Green Light approval and has now begun to open sites to recruitment!

HOPE-e study resumes recruitment of women with painful osteoarthritis in the hand

Main OCTRU

Researchers in Oxford are looking to recruit women who have painful osteoarthritis in joints of their hands, after resuming a study that was paused due to the COVID crisis.